During the initial 12-week phase, you use one vial per weekly session (12 vials total)
The standard protocol begins with 0.25 mg once weekly for four weeks, increasing to 0.5 mg, with further increases to 1 mg or 2 mg only if needed and tolerated
Starting treatment after lactation completes eliminates theoretical infant exposure while allowing mothers to pursue sustainable metabolic health improvements with clinical support
Beta Thalassemia Intermedia : Both genes are affected, but the mutations allow for some beta-globin production
Chang AM, Jakobsen G, Sturis J, et al
The above parameters were detected in the clinical laboratory of the Affiliated Hospital of Zunyi Medical University, and Elecsys ELISA kits were used